The Hospital of Santa Maria Nuova is the oldest hospital still active in Florence, Italy.

During the past decade, S. Maria Nuova Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "S. Maria Nuova Hospital" #1 collaborator was "Biotronik Italia" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "S. Maria Nuova Hospital" are "Bradycardia" (1 trials), "Implantable Cardioverter Defibrillator" (1 trials), "Pacemaker" (1 trials), "Postoperative Pulmonary Complications" (1 trials) and "Sinus Node Disease" (1 trials). Many other conditions were trialed in "S. Maria Nuova Hospital" in a lesser frequency.

Most popular intervention types in "S. Maria Nuova Hospital" are "Device" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "DDD(R)" (1 trials), "DDD+CLS" (1 trials), "Organizational model for remote monitoring" (1 trials) and "XFINE leads" (1 trials). Other intervention names were less common.

The vast majority of trials in "S. Maria Nuova Hospital" are 4 trials for "All" genders.

Currently, there are NaN active trials in "S. Maria Nuova Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in S. Maria Nuova Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in S. Maria Nuova Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".